Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. MDGL.NASDAQ

Madrigal Pharmaceuticals Inc (MDGL NASDAQ) stock market data APIs

$287.67 3.18(1.1%) as of July 26, 2024
Price chart is built with Anychart

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.

Madrigal Pharmaceuticals Inc Financial Data Overview

284.49
287.67
-
289.9115
276.63
119.7604-299.98
5 951 M
21 312 K
0
-7.38
-0.426
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MDGL',
Type: 'Common Stock',
Name: 'Madrigal Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000QS6NV8',
ISIN: NULL,
CUSIP: NULL,
CIK: '1157601',
EmployerIdNumber: '04-3508648',
FiscalYearEnd: 'December',
IPODate: '2007-02-06',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Madrigal Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -453 625 984
  • Earnings Per Share -23.15
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Madrigal Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-07
  • EPS/Forecast -6.28

Get Madrigal Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Madrigal Pharmaceuticals Inc latest news via APIs

Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024

Madrigal Pharmaceuticals, Inc. CONSHOHOCKEN, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its second-quarter 2024 financia...

7 Biotech Stocks to Keep on Your Clinical Radar

Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.
Do you have any questions?
support@eodhistoricaldata.com